Profile of Aureon

Aureon Biosciences is a life science company founded in 2002, dedicated to enabling the advancement of predictive and personalized cancer treatment options. Aureon employs a unique Systems Pathology approach and provides personalized test results by analyzing a patient’s existing biopsy sample using molecular diagnostics, sophisticated tissue-based image analysis and advanced mathematics. The resulting information is objective, predictive and personalized and allows the patient and his doctor to make more-informed treatment decisions.

Aureon’s technology fits smoothly with existing clinical and pathological processes. Aureon examines formalin-fixed, paraffin-embedded (FFPE) specimens that are routinely obtained as tissue biopsies. Many existing methods need to destroy the tissue architecture to extract protein or genetic biomarkers, losing critical biological information in the process. Vitally important, Aureon’s approach retains the biological information embedded in the patient’s tissue resulting in improved test performance.

In addition to our clinical tests, Aureon also collaborates with bio-pharmaceutical partners to apply our innovative platform to drug discovery and clinical development. Although our initial research focus has been on prostate cancer, we have completed pilot projects in other cancer areas and we are interested in working with partners in the areas of non-small cell lung cancer (NSCLC), breast cancer, bladder cancer, and colorectal cancer.

Aureon is a founding member of the 21st Century Medicine Coalition, a member of the Personalized Medicine Coalition, and a member of the American Clinical Laboratory Association (ACLA).

Aureon was co-founded by leading physician-scientists at Memorial Sloan-Kettering Cancer Center, Yale Cancer Center, and Albert Einstein College of Medicine. Our investors include New Leaf Venture Partners/Sprout Group, BD Ventures, Pfizer Strategic Investments and Atlas Venture. Aureon’s central laboratory is located in Yonkers, New York.

> Patients: Learn how Aureon's advanced prostate cancer tests can help you

> Physicians: Learn how our prostate cancer tests can help you make more informed treatment decisions